Article Versions Notes

Conti P, Stellin L, Caraffa A, Gallenga CE, Ross R, Kritas SK, Frydas I, Younes A, Di Emidio P, Ronconi G. Advances in Mast Cell Activation by IL-1 and IL-33 in Sjögren’s Syndrome: Promising Inhibitory Effect of IL-37. International Journal of Molecular Sciences. 2020; 21(12):4297. https://doi.org/10.3390/ijms21124297

Conti, Pio, Luisa Stellin, Alesssandro Caraffa, Carla E. Gallenga, Rhiannon Ross, Spyros K. Kritas, Ilias Frydas, Ali Younes, Paolo Di Emidio, and Gianpaolo Ronconi. 2020. "Advances in Mast Cell Activation by IL-1 and IL-33 in Sjögren’s Syndrome: Promising Inhibitory Effect of IL-37" International Journal of Molecular Sciences 21, no. 12: 4297. https://doi.org/10.3390/ijms21124297

Conti, P., Stellin, L., Caraffa, A., Gallenga, C. E., Ross, R., Kritas, S. K., Frydas, I., Younes, A., Di Emidio, P., & Ronconi, G. (2020). Advances in Mast Cell Activation by IL-1 and IL-33 in Sjögren’s Syndrome: Promising Inhibitory Effect of IL-37. International Journal of Molecular Sciences, 21(12), 4297. https://doi.org/10.3390/ijms21124297